Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pneumonia
Pharma
Paratek's pneumonia antibiotic Nuzyra clinches trial win
Paratek, which was bought out by Novo Holdings and Gurnet Point Capital last year, plans to speak with the FDA about a Nuzyra label update in CABP.
Zoey Becker
Jul 19, 2024 8:28am
Add Sobi's Kineret to the FDA's list of COVID treatments
Nov 9, 2022 5:25pm
Pfizer teams up again with former football pro Terry Bradshaw
Feb 12, 2021 10:25am
Merck wins speedy FDA review for 15-strain pneumonia vaccine
Jan 12, 2021 10:50am
Pneumonia awareness effort illuminates iconic structures
Nov 20, 2020 3:53pm
Merck, Pfizer pneumonia vaccines running low in EU
Oct 23, 2020 10:45am
